The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2023, the acute respiratory distress syndrome (ARDS) market is expected to show significant growth in the forecast period.

The acute respiratory distress syndrome (ARDS) market has exhibited rapid growth, escalating from $1.17 billion in 2023 to an estimated $1.29 billion in 2024, boasting a Compound Annual Growth Rate (CAGR) of 10.6%. This surge is attributed to advancements in critical care medicine, an aging population, the emphasis on pulmonary rehabilitation, and the collaborative efforts of multidisciplinary care teams.

Anticipated Growth Ahead

Forecasted Growth
The acute respiratory distress syndrome (ARDS) market is set to witness a robust future, with projections indicating an expansion to $1.93 billion by 2028, driven by a CAGR of 10.7%. The forecasted growth is underpinned by global healthcare preparedness, ongoing vaccine development, infectious disease management, the integration of telemedicine, remote monitoring, and the adoption of patient-centered care models.

Impact Of Increasing Pneumonia Prevalence

Pneumonia’s Contribution
The escalating prevalence of pneumonia is a pivotal factor propelling the growth of the ARDS market. Pneumonia, an infection affecting the lungs, triggers inflammatory reactions, leading to increased blood vessel permeability and fluid leakage into the alveoli. This fluid buildup hampers the exchange of oxygen and carbon dioxide, resulting in respiratory distress.

Statistics Reflecting Prevalence
As reported by the Centers for Disease Control and Prevention, in 2021, the United States witnessed 41,309 deaths due to pneumonia, with a mortality rate of 12.4 deaths per 100,000 population. This surge in pneumonia cases underscores the crucial role of the ARDS market in addressing respiratory challenges.

View More On The Acute Respiratory Distress Syndrome (ARDS) Market Report 2023 – https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report 

Innovative Drug Development Initiatives

Focus on Innovation
Major players in the ARDS market are prioritizing innovative drug development to sustain their market positions. Notably, Zuventus Healthcare Ltd. launched Aviptadil, a vasoactive intestinal peptide supplement, demonstrating advancements in drug therapy for ARDS. Aviptadil’s unique features include the improvement of breathing, reduction in mortality, and its ability to protect and regenerate lung cells.

Strategic Acquisitions Driving Growth
In January 2022, AcelRx Pharmaceuticals Inc. strategically acquired Lowell Therapeutics Inc. for $32.5 million. This move expands AcelRx Pharmaceuticals’ portfolio and strengthens its position in the pharmaceutical industry. Lowell Therapeutics specializes in products for treating ARDS and disseminated intravascular coagulation, reflecting the significance of strategic acquisitions in enhancing market presence.

Market Segmentation and Strategic Focus

Insights into Segmentation
The ARDS market is segmented based on diagnosis and treatment types, various causes such as COVID-19, sepsis, inhalation of harmful substances, severe pneumonia, and different severity levels including mild, moderate, and severe. The end-users include hospitals, clinics, ambulatory service centers, and other healthcare facilities.

Request A Sample Of The Global Acute Respiratory Distress Syndrome (ARDS) Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=13005&type=smp

The Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2023  provides an in-depth analysis on the acute respiratory distress syndrome (ARDS) market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the acute respiratory distress syndrome (ARDS) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Respiratory Disease Testing Global Market Report 2023
Anesthesia And Respiratory Devices Global Market Report 2023
Respiratory Protection Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model